Search results for “Infiltrating cancer” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 44 patents, we discovered top 16 key players by total patent application. Self-screen BV, CINDA PHARMA AB, Prelude Ltd. are dominant in this area. They take 52.27% of the total patent filing.
Self-screen BV
Noord-Holland, Netherlands
Patent: 13
CINDA PHARMA AB
Sweden
Patent: 7
Prelude Ltd.
United Kingdom
Patent: 3
Ono Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 2
Novartis AG
Basel-Stadt, Switzerland
Patent: 1
Regents of the University of California
California, United States
Patent: 1
Assistance Publique des Hôpitaux de Paris SA
France
Patent: 1
UCL Business Ltd.
United Kingdom
Patent: 1
IntraOp Medical Corp.
California, United States
Patent: 1
Institut National de la Santé et de la Recherche Médicale
France
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 25 patents applied in the last 5 years. We discover 10 most active companies in this area. The fast-growing CINDA PHARMA AB, Self-screen BV, Regents of the University of California take 56.00% of patent filing during this period.
CINDA PHARMA AB
Sweden
Patent: 7
Self-screen BV
Noord-Holland, Netherlands
Patent: 5
Regents of the University of California
California, United States
Patent: 2
Prelude Ltd.
United Kingdom
Patent: 1
Nanjing Nuoyuan Medical Devices Co Ltd.
Jiangsu Sheng, China
Patent: 1
University of Zurich
ZURICH, Switzerland
Patent: 1
Peking Union Medical College Hospital
Beijing Shi, China
Patent: 1
Cancer Hospital Chinese Academy of Medical Sciences
Beijing Shi, China
Patent: 1
The First Affiliated Hospital of Zhengzhou University
Henan Sheng, China
Patent: 1
Beijing Proteome Research Center
undefined undefined
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 25 patents in last 5 years, we discover 7 new entrants. CINDA PHARMA AB, Nanjing Nuoyuan Medical Devices Co Ltd., University of Zurich are the most active new entrants in this area.
CINDA PHARMA AB
Sweden
Patent: 7
Nanjing Nuoyuan Medical Devices Co Ltd.
Jiangsu Sheng, China
Patent: 1
University of Zurich
ZURICH, Switzerland
Patent: 1
Peking Union Medical College Hospital
Beijing Shi, China
Patent: 1
Cancer Hospital Chinese Academy of Medical Sciences
Beijing Shi, China
Patent: 1
The First Affiliated Hospital of Zhengzhou University
Henan Sheng, China
Patent: 1
Beijing Proteome Research Center
undefined undefined
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 19 patents, we discovered top 12 universities and scientific research institutions by total patent application. University of Bonn, The Scripps Research Institute, The Trustees of Columbia University in The City of New York are dominant in this area. They take 47.37% of the total patent filing.
University of Bonn
Nordrhein-Westfalen, Germany
Patent: 4
The Scripps Research Institute
California, United States
Patent: 2
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 1
Yale University
Connecticut, United States
Patent: 1
The Johns Hopkins University
United States
Patent: 1
The Ohio State University
Ohio, United States
Patent: 1
The European Molecular Biology Laboratory
Baden-Württemberg, Germany
Patent: 1
Centre Hospitalier Universitaire de Nice
France
Patent: 1
Université de Paris 5 René Descartes
France
Patent: 1
University of Nice Sophia Antipolis
France
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: